AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05591417 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral Erector spinae plane block with dexamethasone
Description: Patients will receive bilevel erector spinae plane block with bupivacaine and dexamethasone
Study NCT05591417 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral Erector spinae plane block with dexmedetomidine
Description: Patients will receive bilevel erector spinae plane block with bupivacaine and dexmedetomidine
Study NCT05591417 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous morphine
Description: Intravenous morphine 0.1 mg/kg
Study NCT06601270 — intervention group
Intervention type: OTHER
Intervention: There are no interventions as the study is purely observational.
Description: There are no interventions as the study is purely observational.
Study NCT06444789 — intervention group
Intervention type: DEVICE
Intervention: connected smartwatch
Description: The smartwatch is worn by the patient and data are sent automatically to a server that detects if there are signs of RBD.
Study NCT04229758 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anticoagulants
Description: DOAC for the prevention of thromboembolic events in patients with non-valvular AF or VTE.
Study NCT06664372 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trans fontanelle US Guided VP Shunt
Description: Insertion of proximal VP shunt catheter by trans fontanelle US
Study NCT06659315 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Couples Problem Solving Therapy
Description: A couples-based problem solving program to deal with depression, PMTCT adherence, and couple communication.
Study NCT05643625 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pilates exercise and myofascial release
Description: Pilates exercise and myofascial relaxation technique will be applied to the experimental group and pilates exercise will be applied to the control group.
Study NCT05643625 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates exercise and myofascial release
Description: Pilates exercise and myofascial relaxation technique will be applied to the experimental group and pilates exercise will be applied to the control group.
Study NCT05759988 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Outpatient Foley catheter
Description: Outpatient Foley catheter placement for induction of labor
Study NCT04798027 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 mRNA vaccine formulation 1
Description: Pharmaceutical form: Sterile suspension Route of administration: Intramuscular injection
Study NCT04798027 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 mRNA vaccine formulation 2
Description: Pharmaceutical form: Sterile suspension Route of administration: Intramuscular injection
Study NCT04798027 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 mRNA vaccine formulation 3
Description: Pharmaceutical form: Sterile suspension Route of administration: Intramuscular injection
Study NCT04798027 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (0.9% normal saline)
Description: Pharmaceutical form: Liquid Route of administration: Intramuscular injection
Study NCT04376918 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Begin with BVGA
Description: Device: BVGA The BVGA enables the direct connection of a bag valve device to a Guedel, eliminating the need for a face mask during ventilation~Other Names:~• Bag Valve Guedel Adaptor Device: Face Mask Classic face mask
Study NCT05943860 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pantovigar® vegan
Description: Oral application of 1 capsule three times a day (morning, noon, evening) for 6 months
Study NCT05551364 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ATLAS 2030 exoskeleton
Description: Individualized Rehabilitation Treatment with the ATLAS 2030 Exoskeleton consists of the following phases:~1. Telephone contact phase (1 session)~2. Inclusion Phase (1 session)~3. Signing of informed consent (1 session)~4. Initial Evaluation Phase (1 session)~5. Treatment Phase (1st part) (7 sessions)~6. Monthly Evaluation Phase (1 session)~7. Treatment Phase (2nd part) (7 sessions)~8. Monthly Evaluation Phase (1 session)~9. Treatment Phase (3rd part) (7 sessions)~10. Final Evaluation Phase and results (2 sessions)
Study NCT04376918 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Begin with Face-mask
Description: Device: BVGA The BVGA enables the direct connection of a bag valve device to a Guedel, eliminating the need for a face mask during ventilation~Other Names:~• Bag Valve Guedel Adaptor Device: Face Mask Classic face mask
Study NCT06033183 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood sample collection : 2 X 5 ml
Study NCT05754749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iohexol 350 Mg/mL Injectable Solution
Description: Participants will be scanned with the digital breast tomosynthesis (DBT) system before and after the intravenous administration of iodinated contrast agent, iohexol 350mg I/mL at a dose of 1.5 mL/kg body weight. Images will be acquired of the breast of interest prior to the administration of contrast, followed by at approximately 2 minutes and 5 minutes after administration. For the purposes of this study, imaging will focus on a single breast to simplify data acquisition.
Study NCT04943016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD19 Chimeric Antigen Receptor (CAR) T Cells
Description: This study seeks to examine the feasibility and safety of the administration of autologous T cells that have been modified through the introduction of a chimeric antigen receptor targeting the B cell surface antigen CD19 following administration of chemotherapy lymphodepletion regimen in children and adults with relapsed/refractory B cell malignancies. The overall goal of this study is to validate the safety profile of administration CD19 CAR T cells and describe the toxicities in children and adults with relapsed/ refractory B cell malignancies. Each patient implements leukapheresis 2 weeks after enrollment and infuse CD19 CAR-T cell around 2 weeks after leukapheresis, and administrated chemotherapy lymphodepletion regimen 1 week before infusion. Furthermore, the treated subject would be following up around 2 years.
Study NCT05412550 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise self-management
Description: Six walking exercise self-management telehealth sessions will focus on behavior change techniques and personalized action plans. Peer support groups will be held every three months, and will be focused on supporting participants in attaining sustained exercise. Text message prompts will focus on encouraging exercise and health self-management.
Study NCT05412550 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention control
Description: The six individual telehealth sessions, six peer-group sessions, and text message prompts will focus on general health education. No prompts for exercise or health self-management will be given.
Study NCT04857866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XmAb27564
Description: Single ascending dose of XmAb27564
Study NCT04857866 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single dose of placebo
Study NCT05066841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang)
Description: CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang) for 12 weeks
Study NCT05066841 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 10% CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang)
Description: 10% CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang) and 90% starch for 12 weeks
Study NCT06085417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine + dexamethasone
Description: Vital signs were recorded before the block. Peripheral vascular access was established with a 20-gauge catheter and 0.9% NaCl crystalloid solution infusion was started. For sedation, all patients were routinely administered 1mg midazolam intravenously before the procedure. Patients' ASA score, demographic data (age, height, weight), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), SpO₂, sensory and motor block onset times , need for additional sedation, side effects and complications, if any, were recorded. The patients' postoperative sensory block and motor block resolution times, VAS scores at the 0th, 3rd, 6th, 12th and 24th postoperative hours, total opioid and NSAID requirements in the first 24 hours, and analgesia durations were recorded.~During the perioperative period, all patients were monitored for side effects such as nausea, vomiting, tinnitus, metallic taste in the mouth, and drug allergy.
Study NCT05167227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extension for Community Healthcare Outcomes
Description: ECHO is a technology enabled multi-disciplinary team-based care model centered on case-consultation and peer-to-peer sharing of emerging best practices (i.e., teleECHO) to support management of complex cases associated with Long COVID, ME/CFS, and other PIFI.
Study NCT05134740 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TAA-specific CTLs
Description: Each patient will receive 2 infusions at the same dose, 14 days apart, according to the following dose level:~2 x 10\^7/m2
Study NCT06650306 — intervention group
Intervention type: OTHER
Intervention: This study does not involve any interventions
Description: This study does not involve any interventions
Study NCT06085417 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine + magnesium sulphate
Description: Vital signs were recorded before the block. Peripheral vascular access was established with a 20-gauge catheter and 0.9% NaCl crystalloid solution infusion was started. For sedation, all patients were routinely administered 1mg midazolam intravenously before the procedure. Patients' ASA score, demographic data (age, height, weight), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), SpO₂, sensory and motor block onset times , need for additional sedation, side effects and complications, if any, were recorded. The patients' postoperative sensory block and motor block resolution times, VAS scores at the 0th, 3rd, 6th, 12th and 24th postoperative hours, total opioid and NSAID requirements in the first 24 hours, and analgesia durations were recorded.~During the perioperative period, all patients were monitored for side effects such as nausea, vomiting, tinnitus, metallic taste in the mouth, and drug allergy.
Study NCT06085417 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: bupivacaine
Description: bupivacaine
Study NCT06651398 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lenient diet
Description: The interventional goup receives the lenient diet instructions and will eat a light meal until 18h on the day before the colonoscopy. The first dose of Plenvu will be started at 20h. All the other bowel preparation instructions will be the same as in the control group.
Study NCT06264362 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Physical Activity Program
Description: Adaptation of physical activity as an intervention for pain management using the 3-Step Tailored Approach: assessing in Step 1 the Person Living with Dementia (PLWD), in Step 2 the Environment, and in Step 3 the Caregiver. With this approach, traditional exercises can be adapted to 1) functional activities (e.g., stair climbing) that are tailored to the interests (e.g., dancing, boxing) and preserved abilities of PLWD; 2) preferred and well-tolerated environments (e.g., home); and 3) account for extent and type of interventionist and caregiver involvement.
Study NCT04719728 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Aided pure tone audiometry
Description: aided response, speech, evoked potential
Study NCT05887752 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard rehabilitation
Description: Carried out 3h/day, 5 days/week at the Montecatone Institute. It implies a multiprofessional approach through:~* physiotherapy;~* occupational therapy;~* sports rehabilitation.
Study NCT05887752 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard rehabilitation
Description: Carried out 3h/day, 5 days/week at the Montecatone Institute. It implies a multiprofessional approach through:~* physiotherapy;~* occupational therapy;~* sports rehabilitation.
Study NCT05887752 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hunova® rehabilitation
Description: Performed in a dedicated gym of the Montecatone Institute, 1 hour/day, 5 days/week, in the presence of a physiotherapist. Depending on the improvement of the person and of his skills acquisition, the degree of tilting of the Hunova® seat in the various planes may vary.
Study NCT05887752 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hunova® rehabilitation
Description: Performed in a dedicated gym of the Montecatone Institute, 1 hour/day, 5 days/week, in the presence of a physiotherapist. Depending on the improvement of the person and of his skills acquisition, the degree of tilting of the Hunova® seat in the various planes may vary.
Study NCT06551948 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: psyllium
Description: 15 g psyllium
Study NCT06551948 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: methylcellulose
Description: 15 gm methylcellulose
Study NCT06551948 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: maltodextrin
Description: 15 g maltodextrin
Study NCT06551948 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: inulin
Description: 15g inulin
Study NCT06551948 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: inulin
Description: 15g inulin
Study NCT04736147 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JNJ-64300535
Description: JNJ-64300535 injection will be administered intramuscularly.
Study NCT05183139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib
Description: Ixazomib capsules
Study NCT05183139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide capsules
Study NCT05183139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide capsules
Study NCT05183139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone tablets
Study NCT06292039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Human-Centered Injury Thrivorship Pathway
Description: Enrollment in the human-centered injury thrivorship pathway.
Study NCT05454488 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Focal Cryoablation
Description: Participants will have the Focal cryoablation placed by the needles in such a way that the area of affected tissue is much smaller and focus just on the tumor tissue and surrounding area
Study NCT05454488 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care
Description: Participants will receive a prostate biopsy.
Study NCT05454488 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-life Questionnaires
Description: Participants will fill out questionnaires.
Study NCT06651723 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Toothbrush type
Description: The participants will use either an electric soft brush (test) and soft manual brush (control).
Study NCT06651723 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Toothbrush type
Description: The participants will use either an electric soft brush (test) and soft manual brush (control).
Study NCT06653660 — intervention group
Intervention type: OTHER
Intervention: Clinical examination
Description: For the aim of the present study, we will follow-up children born alive in the TIMOUN cohort at peripubertal age. Questionnaires will be administered to parents on the child's health and lifestyle. Stature-weight anthropometric and cardio-dynamic measurements of the child will be obtained. Scores on three cognitive tests will be obtained. Furthermore, steroid hormones and chlordecone in the child's peripheral blood will be determined.
Study NCT06652997 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SPH3348
Description: Single oral administration of SPH3348 tablets（480mg） under fasting and fed conditions
Study NCT06568497 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food
Description: Food
Study NCT05187507 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of the effectiveness of low- fluoridated toothpaste.
Description: Children will be given low- fluoridated toothpaste, plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface.~Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).
Study NCT05187507 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of the effectiveness of fluoridated toothpaste.
Description: Children will be given e fluoridated toothpaste, plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface.~Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).
Study NCT05327400 — intervention group
Intervention type: OTHER
Intervention: Pathological
Description: The pancreatic cancer cohort and the healthy cancer-free patient cohort were divided according to pathology reports
Study NCT04816357 — intervention group
Intervention type: OTHER
Intervention: Questionaire
Description: only questionaire
Study NCT04705545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transpalatal arch group
Description: transpalatal arch is a 1.0 mm stainless steel wire connecting the upper permanent first molar, with a U loop pointing posteriorly, soldered to the palatal side of the molar bands.
Study NCT04705545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nance button
Description: Nance button is a 1.0mm stainless steel wire connecting the upper permanent first molar, with a Nance button incorporated in the middle of the wire, soldered to the palatal side of the molar bands
Study NCT05050188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H008
Description: Drug administration after a minimum 10-hour overnight fasting. Subjects will be instructed to take the drugs with approximately 240 ml (8 oz) room temperature water.
Study NCT05050188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H008 placebo
Description: Drug administration after a minimum 10-hour overnight fasting. Subjects will be instructed to take the drugs with approximately 240 ml (8 oz) room temperature water
Study NCT05050188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Description: Drug administration after a minimum 10-hour overnight fasting. Subjects will be instructed to take the drugs with approximately 240 ml (8 oz) room temperature water
Study NCT06074016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zolmitriptan intranasal.
Description: Zolmitriptan nasal spray is supplied in a single-use, ready-to-use spray unit. It is administered in one nostril. The full protocol will explain how to use it. Following drug administration, study subjects will continue to fast for a minimum of 4h and snacks and standard meals may be served at scheduled times after drug administration (snack: +4h; lunch: +7h; snack: +10h). Liquid intake will not be allowed from 2h before to 2h after drug administration.
Study NCT06074016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zolmitriptan oral.
Description: Zolmitriptan 5 mg orally disintegrating tablet is to be taken without liquids. For oral administration, each tablet will be placed in the top of the tongue without any liquid and will disperse in a matter of seconds, then be swallowed with saliva. Following drug administration, study subjects will continue to fast for a minimum of 4h and snacks and standard meals may be served at scheduled times after drug administration (snack: +4h; lunch: +7h; snack: +10h). Liquid intake will not be allowed from 2h before to 2h after drug administration.
Study NCT05706259 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Soft gelatin 200000 IU vitamin D3 capsule
Description: Weekly single dose for 3-weeks
Study NCT05706259 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Orodispersible (sachet) 200000 IU vitamin D3
Description: Weekly single dose for 3-weeks
Study NCT05187507 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation of the effectiveness of theobromine toothpaste (2%) toothpaste.
Description: Children will be given theobromine toothpaste(2%),plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface.~Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).
Study NCT05187507 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation of the effectiveness of theobromine toothpaste(4%) toothpaste.
Description: Children will be given theobromine toothpaste(4%),plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface.~Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).
Study NCT06604299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meditation-enhanced Cognitive Behavioral Therapy
Description: Self-guided online intervention